Literature DB >> 25732639

Pitfalls of insulin-like growth factor-i and growth hormone assays.

Riia K Junnila1, Christian J Strasburger2, Martin Bidlingmaier3.   

Abstract

Accurate measurement of growth hormone (GH) and insulin-like growth factor-I (IGF-I) are the key to correct diagnosis of acromegaly and GH deficiency. Unfortunately, there is much variation involved when these hormones are measured at different sites and using different assay methods. There is an ongoing global effort to standardize the measurement process to obtain more comparable results in the future. This review discusses common pitfalls in the measurement of GH and IGF-I and guides laboratories in their analyses of these hormones.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Antibody; Binding protein; Growth hormone; Immunoassay; Insulin-like growth factor I; Provocative testing; Standard preparation

Mesh:

Substances:

Year:  2014        PMID: 25732639     DOI: 10.1016/j.ecl.2014.10.003

Source DB:  PubMed          Journal:  Endocrinol Metab Clin North Am        ISSN: 0889-8529            Impact factor:   4.741


  13 in total

1.  Pituitary function and morphology in Fabry disease.

Authors:  Luigi Maione; Fabio Tortora; Roberta Modica; Valeria Ramundo; Eleonora Riccio; Aurora Daniele; Maria Paola Belfiore; Annamaria Colao; Antonio Pisani; Antongiulio Faggiano
Journal:  Endocrine       Date:  2015-04-21       Impact factor: 3.633

Review 2.  The surgical treatment of acromegaly.

Authors:  Michael Buchfelder; Sven-Martin Schlaffer
Journal:  Pituitary       Date:  2017-02       Impact factor: 4.107

3.  Revised GH and cortisol cut-points for the glucagon stimulation test in the evaluation of GH and hypothalamic-pituitary-adrenal axes in adults: results from a prospective randomized multicenter study.

Authors:  Amir H Hamrahian; Kevin C J Yuen; Murray B Gordon; Karen J Pulaski-Liebert; James Bena; Beverly M K Biller
Journal:  Pituitary       Date:  2016-06       Impact factor: 4.107

Review 4.  Growth hormone - past, present and future.

Authors:  Michael B Ranke; Jan M Wit
Journal:  Nat Rev Endocrinol       Date:  2018-03-16       Impact factor: 43.330

5.  Pegvisomant-primed glucagon stimulation test in assessing GH reserve and GH/IGF kinetics in adults suspected of GH deficiency.

Authors:  Kevin C J Yuen; Jan Frystyk; Sharon A Rhoads; Martin Bidlingmaier
Journal:  Pituitary       Date:  2016-02       Impact factor: 4.107

6.  Clinical and hormonal findings in patients presenting with high IGF-1 and growth hormone suppression after oral glucose load: a retrospective cohort study.

Authors:  Giulia Carosi; Alessandra Mangone; Elisa Sala; Giulia Del Sindaco; Roberta Mungari; Arianna Cremaschi; Emanuele Ferrante; Maura Arosio; Giovanna Mantovani
Journal:  Eur J Endocrinol       Date:  2021-07-01       Impact factor: 6.664

7.  Reference Values for IGF-I Serum Concentrations: Comparison of Six Immunoassays.

Authors:  Philippe Chanson; Armelle Arnoux; Maria Mavromati; Sylvie Brailly-Tabard; Catherine Massart; Jacques Young; Marie-Liesse Piketty; Jean-Claude Souberbielle
Journal:  J Clin Endocrinol Metab       Date:  2016-05-11       Impact factor: 5.958

8.  Serum Insulin-like Growth Factor I Quantitation by Mass Spectrometry: Insights for Protein Quantitation with this Technology.

Authors:  Richard Kin Ting Kam; Chung Shun Ho; Michael Ho Ming Chan
Journal:  EJIFCC       Date:  2016-12-01

Review 9.  Update on GH therapy in adults.

Authors:  Cesar Luiz Boguszewski
Journal:  F1000Res       Date:  2017-11-16

10.  Early versus late initiation of GH replacement in adult-onset hypopituitarism.

Authors:  Mark R Postma; Pia Burman; André P van Beek
Journal:  Endocr Connect       Date:  2020-07       Impact factor: 3.335

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.